Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. EMBC

Market Cap: $293.08M

EC

Embecta Corp.

EMBC
NASDAQ (NASDAQ Global Select)USD
Purchase EMBC
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin59.89%
EBITDA Margin26.87%
EBIT Margin21.76%
Pre-tax Margin12.27%
Net Profit Margin8.59%
Earnings Yield30.29%
Valuation Multiples
Price / Book-0.47
Price / Sales0.29
Price / Earnings3.32
PEG0.67
Forward PEG-0.84
EV / Sales1.55
EV / EBITDA5.77
EV / Operating Cash Flow9.08
EV / Free Cash Flow9.60
Price / Free Cash Flow1.78
Price / Operating Cash Flow1.66
Cash Flow & Capital
Free Cash Flow / Share$2.81
Operating Cash Flow / Share$2.98
Free Cash Flow Yield56.16%
Capex / Revenue0.93%
Capex / Operating Cash Flow5.46%
Capex / Depreciation0.26
Stock Compensation / Revenue2.48%
Dividend Payout Ratio31.09%
Dividend Yield6.48%
Liquidity & Leverage
Current Ratio1.68
Quick Ratio1.68
Cash Ratio0.51
Debt / Assets1.19
Debt / Capital1.69
Debt / Equity-2.45
Long-Term Debt / Capital1.87
Debt / Market Cap4.96%
Net Debt / EBITDA4.70
Solvency Ratio0.07
Financial Leverage-2.07
Efficiency & Working Capital
Asset Turnover0.81
Fixed Asset Turnover3.22
Inventory Turnover0.00
Receivables Turnover5.59
Payables Turnover4.51
Days Sales Outstanding65.28
Days Inventory Outstanding0
Days Payables Outstanding80.84
Operating Cycle65.28
Cash Conversion Cycle-15.56
Working Capital Turnover3.15
Returns & Quality
Return on Equity-13.98%
Return on Assets6.92%
Return on Invested Capital17.81%
ROCE29.93%
Return on Tangible Assets7.43%
Operating Return on Assets22.06%
Income Quality1.99
Tax Burden0.70
Interest Burden0.56
Balance Sheet & Intrinsic Metrics
Enterprise Value$1.58B
Invested Capital$689.5M
Working Capital$285.3M
Tangible Asset Value$-700.1M
Net Current Asset Value$-1.17B
Graham Net-Net-$26.11
Book Value / Share-$10.48
Tangible Book Value / Share-$11.97
Cash / Share$3.67
Financial Health Scores
Piotroski Score6
Altman Z-Score1.30
Revenue$1.02B
EBIT$221.7M
Market Cap$290.11M
Working Capital$285.3M
Retained Earnings$-404.3M
Total Assets$1.27B
Total Liabilities$1.88B